Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DepoCyte launched in Europe

Feb. 9, 2004

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

Feb. 9, 2004

Abbott and Caprion collaborate on drug discovery for lung cancer

Feb. 9, 2004

Phase I ThermoDox protocol amendments allowed

Feb. 6, 2004

IP3R3 involved in peritoneal metastasis of gastric cancers

Feb. 6, 2004

Biological effects and safety of MDX-H210 plus filgrastim in advanced breast cancer

Feb. 6, 2004

A phase II clinical trial shows no effects for repifermin in cancer therapy-induced mucositis

Feb. 5, 2004

Registrational satraplatin trial expanded into Europe

Feb. 5, 2004

Two series of protein kinase modulators patented by Cellular Genomics

Feb. 5, 2004

ECO-04601 inhibits tumor growth in animal model of glioma

Feb. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...